Effect of selected antiarrhythmic drugs on the superoxide anion production by polymorphonuclear neutrophils in vitro. 1989

E Wysocka, and H Wysocki, and T Siminiak, and A Szczepanik
Academy of Medicine, Department of Intensive Therapy, Poznan, Poland.

The oxygen radicals produced by polymorphonuclear neutrophils (PMN) during ischemia and reperfusion play an important role in the development of arrhythmias. We investigated the influence of selected antiarrhythmic drugs on PMN superoxide anion production. Amiodarone, verapamil and propranolol significantly decreased the stimulated superoxide anion production, which may be an additional mechanism of their antiarrhythmic activity. The fast sodium channel inhibitors lidocaine, procainamide and mexiletine affected neither spontaneous nor stimulated superoxide anion production.

UI MeSH Term Description Entries
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D013481 Superoxides Highly reactive compounds produced when oxygen is reduced by a single electron. In biological systems, they may be generated during the normal catalytic function of a number of enzymes and during the oxidation of hemoglobin to METHEMOGLOBIN. In living organisms, SUPEROXIDE DISMUTASE protects the cell from the deleterious effects of superoxides. Superoxide Radical,Superoxide,Superoxide Anion
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

E Wysocka, and H Wysocki, and T Siminiak, and A Szczepanik
January 1993, Nephron,
E Wysocka, and H Wysocki, and T Siminiak, and A Szczepanik
September 1987, The Biochemical journal,
E Wysocka, and H Wysocki, and T Siminiak, and A Szczepanik
January 2000, Acta diabetologica,
E Wysocka, and H Wysocki, and T Siminiak, and A Szczepanik
September 1999, The Journal of antimicrobial chemotherapy,
E Wysocka, and H Wysocki, and T Siminiak, and A Szczepanik
June 1994, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
E Wysocka, and H Wysocki, and T Siminiak, and A Szczepanik
January 1999, Life sciences,
E Wysocka, and H Wysocki, and T Siminiak, and A Szczepanik
January 1997, BioFactors (Oxford, England),
E Wysocka, and H Wysocki, and T Siminiak, and A Szczepanik
November 1987, [Rinsho ketsueki] The Japanese journal of clinical hematology,
E Wysocka, and H Wysocki, and T Siminiak, and A Szczepanik
June 1983, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
E Wysocka, and H Wysocki, and T Siminiak, and A Szczepanik
May 1989, The Journal of allergy and clinical immunology,
Copied contents to your clipboard!